Structure-activity relationship of (1-aryl-2-piperazinylethyl)piperazines: Antagonists for the AGRP/melanocortin receptor binding

被引：37
|
作者：
Arasasingham, PN
Fotsch, C
Ouyang, X
Norman, MH
Kelly, MG
Stark, KL
Karbon, B
Hale, C
Baumgartner, JW
Zambrano, M
Cheetham, J
Tamayo, NA
机构：
[1] Amgen Inc, Dept Small Molecule Drug Discovery, Thousand Oaks, CA 91320 USA
[2] Amgen Inc, Dept Metab Disorders, Thousand Oaks, CA 91320 USA
来源：
JOURNAL OF MEDICINAL CHEMISTRY | 2003年 / 46卷 / 01期
关键词：
D O I：
10.1021/jm0255522
中图分类号：
R914 [药物化学];
学科分类号：
100701 ;
摘要：
Agouti-related protein (AGRP) is an endogenous antagonist of the melanocortin action.(1) In the hypothalamus, melanocortin peptide agonists act as satiety-inducing factors that mediate their action through the melanocortin-4 receptor (MC4R) whereas AGRP is an opposing orexigenic agent. Novel inhibitors of the AGRP/MC4 binding based on (piperazinylethyl)piperazines were prepared, and their structure-activity relationship was established.
引用
收藏
页码：9 / 11
页数：3
相关论文
共 50 条
  • [41] Structure-activity relationship of a series of diaminoalkyl substituted benzimidazole as neuropeptide Y Y1 receptor antagonists
    Zarrinmayeh, H
    Zimmerman, DM
    Cantrell, BE
    Schober, DA
    Bruns, RF
    Gackenheimer, SL
    Ornstein, PL
    Hipskind, PA
    Britton, TC
    Gehlert, DR
    BIOORGANIC & MEDICINAL CHEMISTRY LETTERS, 1999, 9 (05) : 647 - 652
  • [42] Synthesis and structure-activity relationship of the potent antagonists of VLA-1 integrin
    VanBrunt, Michael Pete
    Kasar, Ramesh
    Kolakowski, Gabrielle R.
    Jacobson, Irina C.
    Harris, Edith A. S.
    Sui, Li-ming
    Lupher, Mark L., Jr.
    Staunton, Donald S.
    Farouz, Francine
    Thorsett, Eugene D.
    ABSTRACTS OF PAPERS OF THE AMERICAN CHEMICAL SOCIETY, 2006, 231
  • [43] Structure-activity relationship studies of carboxamido-biaryl ethers as opioid receptor antagonists (OpRAs). Part 1
    Takeuchi, Kumiko
    Holloway, William G.
    McKinzie, Jamie H.
    Suter, Todd M.
    Statnick, Michael A.
    Surface, Peggy L.
    Emmerson, Paul J.
    Thomas, Elizabeth M.
    Siegel, Miles G.
    Matt, James E.
    Wolfe, Chad N.
    Mitch, Charles H.
    BIOORGANIC & MEDICINAL CHEMISTRY LETTERS, 2007, 17 (19) : 5349 - 5352
  • [44] Relevance of theoretical molecular descriptors in quantitative structure-activity relationship analysis of α1-adrenergic receptor antagonists
    Menziani, MC
    Montorsi, M
    De Benedetti, PG
    Karelson, M
    BIOORGANIC & MEDICINAL CHEMISTRY, 1999, 7 (11) : 2437 - 2451
  • [45] Structure-activity relationship and target investigation of 2-aryl quinolines with nematocidal activity
    Shanley, Harrison T.
    Taki, Aya C.
    Nguyen, Nghi
    Wang, Tao
    Byrne, Joseph J.
    Ang, Ching-Seng
    Leeming, Michael G.
    Nie, Shuai
    Williamson, Nicholas
    Zheng, Yuanting
    Young, Neil D.
    Korhonen, Pasi K.
    Hofmann, Andreas
    Chang, Bill C. H.
    Wells, Tim N. C.
    Haberli, Cecile
    Keiser, Jennifer
    Jabbar, Abdul
    Sleebs, Brad E.
    Gasser, Robin B.
    INTERNATIONAL JOURNAL FOR PARASITOLOGY-DRUGS AND DRUG RESISTANCE, 2024, 24
  • [46] 6-Acylamino-2-aminoquinolines as potent melanin-concentrating hormone 1 receptor antagonists.: Identification, structure-activity relationship, and investigation of binding mode
    Ulven, T
    Frimurer, TM
    Receveur, JM
    Little, PB
    Rist, O
    Norregaard, PK
    Högberg, T
    JOURNAL OF MEDICINAL CHEMISTRY, 2005, 48 (18) : 5684 - 5697
  • [47] The design, synthesis and structure-activity relationships of 1-aryl-4-aminoalkylisoquinolines: A novel series of CRF-1 receptor antagonists
    Yoon, Taeyoung
    De Lombaert, Stephane
    Brodbeck, Robbin
    Gulianello, Michael
    Chandrasekhar, Jayaraman
    Horvath, Raymond F.
    Ge, Ping
    Kershaw, Mark T.
    Krause, James E.
    Kehne, John
    Hoffman, Diane
    Doller, Dario
    Hodgetts, Kevin J.
    BIOORGANIC & MEDICINAL CHEMISTRY LETTERS, 2008, 18 (03) : 891 - 896
  • [48] Discovery and Structure-Activity Relationship of a Ryanodine Receptor 2 Inhibitor
    Ishida, Ryosuke
    Zeng, Xi
    Kurebayashi, Nagomi
    Murayama, Takashi
    Mori, Shuichi
    Kagechika, Hiroyuki
    CHEMICAL & PHARMACEUTICAL BULLETIN, 2024, 72 (04) : 399 - 407
  • [49] Structure-activity relationship studies on 2-heteroaryl-4-arylimidazoles NPY5 receptor antagonists
    Elliott, RL
    Oliver, RM
    LaFlamme, JA
    Gillaspy, ML
    Hammond, M
    Hank, RF
    Maurer, TS
    Baker, DL
    DaSilva-Jardine, PA
    Stevenson, RW
    Mack, CM
    Cassella, JV
    BIOORGANIC & MEDICINAL CHEMISTRY LETTERS, 2003, 13 (20) : 3593 - 3596
  • [50] Dual A1/A3 Adenosine Receptor Antagonists: Binding Kinetics and Structure-Activity Relationship Studies Using Mutagenesis and Alchemical Binding Free Energy Calculations
    Stampelou, Margarita
    Suchankova, Anna
    Tzortzini, Efpraxia
    Dhingra, Lakshiv
    Barkan, Kerry
    Lougiakis, Nikolaos
    Marakos, Panagiotis
    Pouli, Nicole
    Ladds, Graham
    Kolocouris, Antonios
    JOURNAL OF MEDICINAL CHEMISTRY, 2022, 65 (19) : 13305 - 13327
12345